Epoxiconazole
CAS No. 133855-98-8
Epoxiconazole( BAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2 )
Catalog No. M27138 CAS No. 133855-98-8
Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 90 | In Stock |
|
| 100MG | 146 | In Stock |
|
| 200MG | 220 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEpoxiconazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
In Vitro——
-
In Vivo——
-
SynonymsBAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptorδ-opioid receptor| μ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133855-98-8
-
Formula Weight329.76
-
Molecular FormulaC17H13ClFN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (303.25 mM)
-
SMILESFc1ccc(cc1)C1(Cn2cncn2)OC1c1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mónica García, et al. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ 1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. J Med Chem. 2020 Oct 16.
molnova catalog
related products
-
SIG1459
SIG1459 (SIG-1459) is a novel anti-acne isoprenylcysteine (IPC) small molecule that shows direct antibacterial activity and inhibits TLR2 inflammatory signaling.
-
Cefathiamidine
Cefathiamidine??exhibits a wide spectrum of antimicrobial activity against bacteria.?Cefathiamidine is used for the treatment of respiratory liver five senses urinary tract infections endocarditis and sepsis.
-
Kasugamycin hydrochl...
Kasugamycin hydrochloride hydrate(Ksg) specifically inhibits translation initiation of canonical but not of leaderless messenger RNAs. Ksg inhibition is thought to occur by direct competition with initiator transfer RNA.
Cart
sales@molnova.com